Efficacy of single-inhaler triple therapies for chronic obstructive pulmonary disease: a systematic review and network meta-analysis

Yu Zhang; Pei Zhao; Yudong Zhang

doi:10.1186/s12890-026-04298-9

Efficacy of single-inhaler triple therapies for chronic obstructive pulmonary disease: a systematic review and network meta-analysis

BMC Pulm Med. 2026 Apr 17. doi: 10.1186/s12890-026-04298-9. Online ahead of print.

Authors

Yu Zhang^#^{1

2

3}, Pei Zhao^#^{1

2

3}, Yudong Zhang^{4

5}

Affiliations

¹ Department of Clinical Laboratory, Hebei General Hospital, Shijiazhuang, 050051, China.
² Hebei Key Laboratory of Molecular Medicine, Shijiazhuang, 050070, China.
³ Hebei Clinical Research Center for Laboratory Medicine, Shijiazhuang, 050070, China.
⁴ Department of Neonatology, Children's Hospital of Hebei Province, Shijiazhuang, 050031, China. zyd18203319863@163.com.
⁵ Hebei Clinical Medicine Research Center for Children's Health and Diseases, Shijiazhuang, 050031, China. zyd18203319863@163.com.

^# Contributed equally.

PMID: 41998645
DOI: 10.1186/s12890-026-04298-9

No abstract available

Keywords: Beclomethasone dipropionate/ formoterol fumarate/glycopyrronium bromide (BDP/FOR/GLY); Budesonide/formoterol fumarate/glycopyrronium bromide (BUD/FOR/GLY); Chronic obstructive pulmonary disease; Fluticasone furoate/formoterol fumarate/glycopyrronium bromide (FF/FOR/GLY); Fluticasone furoate/vilanterol/umeclidinium (FF/VIL/UMEC); Single-inhaler triple therapy.

Publication types

Systematic Review